Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease plasmacytoma
Phenotype C0085110|severe combined immunodefic
Sentences 1
PubMedID- 20560971 In non-obese diabetic/severe combined immunodeficient mice implanted with h929 human plasmacytoma xenografts, oral treatment with enmd-2076 (50, 100, 200 mg/kg per day) resulted in a dose-dependent inhibition of tumour growth.

Page: 1